CUE BIOPHARMA INC (CUE): Ownership & Insider Activity
Hedge funds and institutional managers reporting a position in CUE. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
3
13F filers
Aggregate Value
$4.0M
Across holders
Last Price
$4.76
2026-11-18
Sector
—
GICS
Quarterly fund activity2 increased1 reduced0 exited
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| Tetragon Partners GP Ltd CIK 0001515070 | Hedge Fund | 94K | $3.0M | 73.4% | 0.5% | Added | — | Q2 2026 |
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 26K | $809K | 20.0% | 0.0% | Added | — | Q2 2026 |
| RENAISSANCE TECHNOLOGIES LLC CIK 0001037389 | Hedge Fund | 10K | $266K | 6.6% | 0.0% | Reduced | $-114K | Q3 2026 |
Recent insider activity
Form 4 purchases and sales · 22 Aug 2026 – 19 Nov 20260 buyers · $03 sellers · $389K4 transactions
| Insider ⇅ | Trades ⇅ | Bought ⇅ | Sold ⇅ | Largest ⇅ | Latest ▼ | |
|---|---|---|---|---|---|---|
| Lin Shao-Lee Chief Executive Officer | 2 0 buy · 2 sell | — | $305K | $275K | 12 Oct 2026SEC ↗ | |
| Meluzio Michael Vincent VP, Prin. Accounting Officer | 1 0 buy · 1 sell | — | $32K | $32K | 12 Oct 2026SEC ↗ | |
| Ray Sumita Chief Legal Compliance Officer | 1 0 buy · 1 sell | — | $52K | $52K | 12 Oct 2026SEC ↗ |
Distinct buyers and sellers may overlap. “Largest” is the largest reported transaction value in this window. Expand a row to see up to five recent filings.